Results

IDEAYA Biosciences Inc.

12/07/2021 | Press release | Distributed by Public on 12/07/2021 06:05

IDEAYA Reports Clinical Data from Phase 2 Expansion Dose of Darovasertib and Crizotinib Synthetic Lethal Combination in Heavily Pre-Treated Metastatic Uveal Melanoma